CDC funds $1.6M hepatitis B vaccine safety study amid ethics debate

The U.S. Centers for Disease Control and Prevention has allocated $1.6 million for a study on alleged harms of the hepatitis B vaccine. The proposed trial has reportedly drawn criticism from some experts who call it unethical. The controversy centers on whether the study's design is scientifically and ethically sound. The CDC has not yet publicly commented on the specific allegations of wrongdoing.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in